View ValuationCroda International 향후 성장Future 기준 점검 4/6Croda International (는) 각각 연간 24.9% 및 4.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 25% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.8% 로 예상됩니다.핵심 정보24.9%이익 성장률24.96%EPS 성장률Chemicals 이익 성장31.8%매출 성장률4.8%향후 자기자본이익률11.77%애널리스트 커버리지Good마지막 업데이트09 Jun 2026최근 향후 성장 업데이트공시 • Oct 17Croda International plc Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal Year 2025Croda International Plc provided earnings guidance for the fourth quarter and full year of fiscal year 2025. For the quarter, the company absolute sales in quarter 4 are likely to be seasonally lower than in the first 3 quarters as customers typically manage their working capital into the year-end. Despite this, the combination of good sales growth year-to-date and anticipated cost savings means that the company continue to expect GBP 265 million to GBP 295 million of group adjusted profit before tax at constant currency. For the full year, the company reiterated full year guidance.모든 업데이트 보기Recent updates공시 • Apr 25Croda International plc Approves Final DividendCroda International Plc at its AGM held on April 22, 2026 approved a final dividend of 63.0 pence per ordinary share.공시 • Feb 25Croda International Plc, Annual General Meeting, Apr 22, 2026Croda International Plc, Annual General Meeting, Apr 22, 2026.공시 • Feb 24Croda International plc Recommends Final Dividend for the Financial Year Ended December 31, 2025, Payable on 27 May 2026Croda International Plc announced that the Directors are recommending a final dividend of 63 pence per share amounting to a total of £87.9 million in respect of the financial year ended 31 December 2025. Subject to shareholder approval, the dividend will be paid on 27 May 2026 to shareholders registered on 10 April 2026. The total proposed dividend for the year ended 31 December 2025 will be 111 pence per share amounting to £154.9 million.공시 • Jan 09Croda International Plc Announces Appointment of Jill Anderson as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees, Effective January 12, 2026Croda International Plc announced the appointment of Jill Anderson as a Non-Executive Director. Jill will join the Board on January 12, 2026 and become a member of the Audit, Nomination and Remuneration Committees. Jill brings more than 30 years' experience in international leadership positions in the healthcare industry, including executive responsibility in finance, commercial research and supply chain functions. Most recently, Jill was Chief Financial Officer of GSK's R&D division until she retired in 2024. Jill is currently a Non-Executive Director and Audit Committee Chair at Spire Healthcare Group plc.공시 • Dec 24+ 1 more updateCroda International Plc to Report Fiscal Year 2026 Results on Feb 23, 2027Croda International Plc announced that they will report fiscal year 2026 results on Feb 23, 2027공시 • Oct 17Croda International plc Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal Year 2025Croda International Plc provided earnings guidance for the fourth quarter and full year of fiscal year 2025. For the quarter, the company absolute sales in quarter 4 are likely to be seasonally lower than in the first 3 quarters as customers typically manage their working capital into the year-end. Despite this, the combination of good sales growth year-to-date and anticipated cost savings means that the company continue to expect GBP 265 million to GBP 295 million of group adjusted profit before tax at constant currency. For the full year, the company reiterated full year guidance.공시 • Jul 31Croda International plc Announces an Interim Dividend in Respect of 2025, Payable on 7 October 2025Croda International Plc announced an interim dividend in respect of 2025 of 48.0 pence per share, amounting to a total dividend of £67.0 million, was declared by the Directors at their meeting on 25 July 2025. This interim report does not reflect the 2025 interim dividend payable. The dividend will be paid on 7 October 2025 to shareholders registered on 29 August 2025.공시 • Mar 04Croda International Plc Announces Retirement of Julie Kim from the Board, Effective July 26, 2025Croda International Plc announced that Julie Kim will retire from the Board on 26 July 2025, having served four years as a non-executive director, in order to focus on her executive commitments. Julie has recently been named as the next CEO of Takeda Pharmaceutical.공시 • Feb 26Croda International Plc, Annual General Meeting, Apr 23, 2025Croda International Plc, Annual General Meeting, Apr 23, 2025.공시 • Feb 25Croda International plc Recommends Final Dividend for the Financial Year Ended December 31, 2024, Payable on May 28, 2025The Directors of Croda International Plc are recommending a final dividend of 63 pence per share amounting to a total of £87.9 million in respect of the financial year ended 31 December 2024. Subject to shareholder approval, the dividend will be paid on 28 May 2025 to shareholders registered on 11 April 2025. The total proposed dividend for the year ended 31 December 2024 will be 110 pence per share amounting to £153.5 million. The Board is proposing to increase the full year dividend to 110 pence (2023: 109 pence), despite temporarily taking company above its stated percentage of adjusted profit after tax, reflecting its confidence in delivery of future earnings growth.공시 • Jan 22+ 1 more updateCroda International Plc to Report Fiscal Year 2025 Results on Feb 24, 2026Croda International Plc announced that they will report fiscal year 2025 results on Feb 24, 2026공시 • Nov 19Croda International plc Announces Directorate ChangeCroda International Plc announced that John Ramsay, having served as a non-executive director and Chair of Audit Committee for over 5 years, will retire from the Board on 1 March 2025 and not seek re-election at the 2025 AGM (due to increased business and personal commitments). In preparation for John's retirement next year, Ian Bull will take over as Chair of the Audit Committee with effect from 1 December 2024 and so lead the Committee over Croda's 2024 year-end. Ian has been a member of the Audit Committee since his appointment to the Board on 24 June 2024. Ian is currently the Audit Committee Chair of Dunelm Group plc, Senior Independent Director at Domino's Pizza Group plc and Fellow of the Chartered Institute of Management Accountants. John will remain a member of the Audit Committee, as well as the Nomination and Remuneration Committees until his retirement from the Board.공시 • Jul 01+ 1 more updateStephen Oxley to Join Croda International plc as Executive Director No Later Than 1 April 2025Croda International Plc announced that the Board has appointed Stephen Oxley as Executive Director. Stephen, a qualified accountant, is currently CFO of Johnson Matthey Plc, the specialty chemicals and sustainable technologies company. Stephen brings valuable experience in strategy setting and execution, enhancing business performance, transformation and corporate transactions. Stephen was previously a Partner at KPMG where he spent nearly 30 years advising global companies across consumer, healthcare and industrial sectors. He is also a Non-Executive Member of the Audit and Risk Committee for the Sovereign Grant which oversees the UK's public grant to the Royal Family. Stephen will join Croda no later than April 1, 2025 following a notice period. Anthony Fitzpatrick,President Strategy, Corporate Development & Industrial Specialties, has been appointed Interim Chief Financial Officer. Anthony joined Croda and the Executive Committee in 2014 having previously spent more than 20 years in global investment banking.공시 • Jun 27Croda International Plc Appoints Ian Bull as Non-Executive Director and Member of the Audit, Nomination and Remuneration CommitteesThe Board of Croda International Plc announced the appointment of Ian Bull as a Non-Executive Director with effect from 25 June 2024. Ian has extensive experience with listed companies across a wide range of industries, both domestic and international, both as an Executive Director as well as Senior Independent Director and Audit Committee Chair. He was previously Group Finance Director of Greene King plc, Chief Financial Officer at Ladbrokes plc, and was most recently Chief Financial Officer of Parkdean Resorts Group. Ian was formerly a non-executive Director of Paypoint Ltd, Chair of Lookers plc and Senior Independent Director and Audit Committee Chair of St. Modwen Properties plc. Ian is currently a Non-Executive Director and Audit Committee Chair of Dunelm Group plc and Senior Independent Director of Domino's Pizza Group Plc. He is a Fellow of the Chartered Institute of Management Accountants. On joining the Board, Ian will be appointed to the Audit, Nomination and Remuneration Committees.공시 • Apr 27Croda International Plc Declares Final DividendCroda International Plc at its Annual General Meeting held on 24 April 2024 declared a final dividend of 62.0 pence per ordinary share.공시 • Feb 29Croda International plc Recommends Final Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on 29 May 2024The Directors of Croda International Plc are recommending a final dividend of 62.0 pence per share amounting to a total of £86.5m in respect of the financial year ended 31 December 2023. Subject to shareholder approval, the dividend will be paid on 29 May 2024 to shareholders registered on 19 April 2024. The total proposed dividend for the year ended 31 December 2023 will be 109.0pper share amounting to £152.1m.공시 • Jan 30+ 1 more updateCroda International Plc to Report First Half, 2024 Results on Jul 30, 2024Croda International Plc announced that they will report first half, 2024 results on Jul 30, 2024공시 • Dec 20Croda International plc Announces Louisa Burdett, Chief Financial Officer, Intends to Leave in June 2024Croda International Plc announced that Louisa Burdett, Chief Financial Officer, intends to leave the Company in June 2024 to become Chief Financial Officer at Spirax-Sarco Engineering plc.공시 • Dec 19Croda International plc Announces Resignation of Louisa Burdett from BoardCroda International Plc announced that Louisa Burdett, Non-Executive Director, will leave the board in June 2024.공시 • Sep 22+ 1 more updateCroda International Plc, Annual General Meeting, Apr 24, 2024Croda International Plc, Annual General Meeting, Apr 24, 2024.공시 • Jul 06Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370).Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW 350 billion on February 3, 2023. The acquisition is subject to regulatory approval. Lazard & Co., Limited acted as financial advisor to Croda International Plc (LSE:CRDA).Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) on July 4, 2023. The acquisition comes following receipt of unconditional approval from the South Korean regulatory authorities.공시 • Feb 07Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion.Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion on February 6, 2023. The acquisition is subject to regulatory approval.공시 • Nov 07Croda International plc Announces Directorate ChangesCroda International Plc announced that Jez Maiden, Group Finance Director, has advised the Board that he will be retiring from the Company during 2023 after eight years in the role. The Board has appointed Louisa Burdett, until recently Chief Financial Officer ("CFO") of Meggitt Plc ("Meggitt"), the global aerospace, defence and energy component manufacturer, to succeed Jez. Jez joined Croda in January 2015, subsequently transforming the Finance, IT and Digital functions, and developing a broad, diverse pool of talent. He has modernised Croda's processes, introduced new standards of operational excellence and financial reporting, and closely supported the Chief Executive in the development and deployment of Croda's strategy. Jez led the creation of Croda's sustainability metrics, as well as its approach to capital allocation, which has underpinned shareholder value creation by enabling investment in organic growth, targeted acquisitions and strong returns. He also co-led the successful separation of the majority of Croda's Performance Technology and Industrial Chemicals businesses, accelerating the Company's transition to be a pure-play Consumer Care and Life Sciences business. Louisa has over ten years of experience successfully leading finance functions for UK listed companies. This includes four years as CFO of Meggitt, before it was acquired by Parker-Hannifin in September 2022, and five years as CFO of Victrex, the speciality chemicals company. Prior to that she held CFO positions with Optos plc, Financial Times Group, GE Healthcare, and CHEP Europe. Louisa is also Non-executive Director and Audit Committee Chair of RS Group Plc, the FTSE 100 distributor of industrial and electronic products. She has a first-class degree in biochemistry from Imperial College London and trained as an accountant before moving into her first in-house role at GSK. To enable a smooth transition, Louisa will join Croda and the Board on 1 January 2023. She will succeed Jez as Group Finance Director on 13 March 2023, following Croda's 2022 Full Year results at the end of February. Jez will step down from the Board at the Annual General Meeting on 26 April 2023 and retire from the Company on 31 May 2023.공시 • Jul 23Croda International Plc Announces Board and Committee ChangesCroda International Plc announced that Dr Helena Ganczakowski will have served nine years as a director of Croda International Plc in 2023 and will therefore retire from the Board on 26 April 2023 following the AGM. In preparation for Helena's retirement next year, Jacqui Ferguson will take over as Chair of the Remuneration Committee with effect from 1 September 2022. This will give Jacqui a good period as Chair to prepare for the Committee's review of the Company's remuneration policy at the end of the year. Jacqui has been a member of the Remuneration Committee since 1 September 2018. Helena will remain a member of the Remuneration Committee and will continue in her role as the Senior Independent Director until her retirement from the Board.공시 • Jul 02Cargill, Incorporated completed the acquisition of 77% stake in Performance Technologies and Industrial Chemicals Businesses from Croda International Plc (LSE:CRDA).Cargill, Incorporated signed a definitive agreement to acquire 77% stake in Performance Technologies and Industrial Chemicals Businesses from Croda International Plc (LSE:CRDA) for approximately £670 million on December 22, 2021. The divested business, which represented 77% of PTIC's 2020 revenue, is comprised of five manufacturing facilities, including the Gouda plant in the Netherlands, the Hull plant in the UK and Croda Sipo in China (a joint venture in which Croda owns 65%), together with additional laboratory facilities supporting key aspects of the divested business' activities in Smart Materials, Energy Technologies and Industrial Chemicals. The consideration of £780 million includes 100% of Sipo in the divested business. If the sale of 100% of Sipo cannot be realised, Sipo will be excluded from the sale, reducing the consideration by approximately £120 million. PTIC reported revenue of approximately £500 million and adjusted operating profit was £55.9 million for the period end on June 30, 2021. Croda intends to reinvest proceeds from the transaction into faster growth areas, increasing its exposure to health care and further developing its position as a sustainability leader in consumer care and crop care markets. The transaction is subject to receiving customary regulatory approvals but is not subject to approval by Croda's or Cargill's shareholders. Croda and Cargill are currently working together on the process to separate the two businesses, with completion of the transaction expected in Summer 2022. Shirav Patel and Andrew Foster of Morgan Stanley & Co. International Plc acted as financial advisors; James Hartop of Centerview Partners LLC acted as financial advisor; Oliver Lazenby, Giles Pratt, Holly Baker, Alastair Chapman, Alice Greenwell, Dawn Heath and Peter Clements of Freshfields Bruckhaus Deringer LLP acted as legal advisor; and Charlie Armitstead of Teneo Securities LLC acted as financial advisor to Croda in the transaction. HSBC is acting as a Sole Financial Adviser to Cargill Inc. Cargill, Incorporated completed the acquisition of 77% stake in Performance Technologies and Industrial Chemicals Businesses from Croda International Plc (LSE:CRDA) on July 1, 2022.공시 • May 24Croda International plc Announces Final Dividend for the Financial Year Ended 31 December 2021Croda International Plc at the Annual General Meeting held on May 20, 2022 declared a final dividend of 56.5 pence per share of the financial year ended 31 December 2021.공시 • Mar 04+ 2 more updatesCroda International Plc to Report Fiscal Year 2022 Results on Mar 07, 2023Croda International Plc announced that they will report fiscal year 2022 results on Mar 07, 2023공시 • Mar 02Croda International plc Recommends Final Dividend for the Year Ended December 31, 2021, Payable on June 6, 2022Croda International Plc's directors are recommending a final dividend of 56.5 pence per share amounting to a total of £78.8 million in respect of the financial year ended 31 December 2021. Subject to shareholder approval, the dividend will be paid on 6 June 2022 to shareholders registered on 6 May 2022. The total proposed dividend for the year ended 31 December 2021 will be 100.0 pence per share amounting to £139.4 million.공시 • Dec 24+ 1 more updateCargill Velocity Holdings Limited agreed to acquire an unknown majority stake in Bio-based industrial business from Croda International Plc (LSE:CRDA) for an enterprise value of approximately €920 million.Cargill Velocity Holdings Limited agreed to acquire an unknown majority stake in Bio-based industrial business from Croda International Plc (LSE:CRDA) for an enterprise value of approximately €920 million on December 22, 2021. The consideration is on a cash-free, debt-free basis. The divested business, which represented 77% of PTIC’s 2020 revenue, is comprised of five manufacturing facilities, including the Gouda plant in the Netherlands, the Hull plant in the UK and Croda Sipo in China (a joint venture in which Croda owns 65%), together with additional laboratory facilities supporting key aspects of the divested business’ activities in Smart Materials, Energy Technologies and Industrial Chemicals. The consideration of €915 million includes 100% of Sipo in the divested business. If the sale of 100% of Sipo cannot be realised, Sipo will be excluded from the sale, reducing the consideration by €140 million. The retained parts of PTIC will provide integral support to the Group’s Consumer Care and Life Sciences sectors. For last twelve month Bio-based industrial business reported revenue of €449.7 million and adjusted operating profit of €57.7 million. The transaction is subject to receiving customary regulatory approvals but is not subject to approval by Croda’s or Cargill’s shareholders. Croda and Cargill are currently working together on the process to separate the two businesses, with completion of the transaction expected in Summer 2022. Croda intends to reinvest proceeds from the transaction into faster growth areas, increasing its exposure to health care and further developing its position as a sustainability leader in consumer care and crop care markets.이익 및 매출 성장 예측LSE:50GP - 애널리스트 향후 추정치 및 과거 재무 데이터 (GBP Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20281,9452462493511212/31/20271,8582152113181312/31/20261,7751781532691312/31/20251,69962167287N/A9/30/20251,684101119254N/A6/30/20251,66814072221N/A3/31/20251,648149105270N/A12/31/20241,628159138319N/A9/30/20241,629161163354N/A6/30/20241,630163189388N/A3/31/20241,662167169363N/A12/31/20231,695171149338N/A9/30/20231,769182172355N/A6/30/20231,843194196373N/A3/31/20231,966422176340N/A12/31/20222,089649156308N/A9/30/20222,086680151297N/A6/30/20222,083711145286N/A3/31/20221,986516167317N/A12/31/20211,890321189348N/A9/30/20211,771284166322N/A6/30/20211,651247144296N/A3/31/20211,521224155291N/A12/31/20201,390202166287N/A9/30/20201,363204N/AN/AN/A6/30/20201,336207181299N/A3/31/20201,357216187301N/A12/31/20191,378224193304N/A9/30/20191,388230N/AN/AN/A6/30/20191,399235N/A278N/A3/31/20191,393237N/A270N/A12/31/20181,387239N/A262N/A9/30/20181,378241N/A265N/A6/30/20181,369244N/A269N/A3/31/20181,371241N/A266N/A12/31/20171,373237N/A263N/A9/30/20171,358226N/A267N/A6/30/20171,342214N/A272N/A3/31/20171,293206N/A268N/A12/31/20161,244197N/A264N/A9/30/20161,185192N/A247N/A6/30/20161,126187N/A230N/A3/31/20161,104184N/A219N/A12/31/20151,082181N/A208N/A9/30/20151,078178N/A201N/A6/30/20151,074175N/A194N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 50GP 의 연간 예상 수익 증가율(24.9%)이 saving rate(3.4%)보다 높습니다.수익 vs 시장: 50GP 의 연간 수익(24.9%)이 UK 시장(11.5%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: 50GP 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 50GP 의 수익(연간 4.8%)이 UK 시장(연간 4.5%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 50GP 의 수익(연간 4.8%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 50GP의 자본 수익률은 3년 후 11.8%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/09 06:00종가2026/05/14 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Croda International Plc는 32명의 분석가가 다루고 있습니다. 이 중 13명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관James KnightBarclaysKatie RichardsBarclaysAmy LianBarclays29명의 분석가 더 보기
공시 • Oct 17Croda International plc Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal Year 2025Croda International Plc provided earnings guidance for the fourth quarter and full year of fiscal year 2025. For the quarter, the company absolute sales in quarter 4 are likely to be seasonally lower than in the first 3 quarters as customers typically manage their working capital into the year-end. Despite this, the combination of good sales growth year-to-date and anticipated cost savings means that the company continue to expect GBP 265 million to GBP 295 million of group adjusted profit before tax at constant currency. For the full year, the company reiterated full year guidance.
공시 • Apr 25Croda International plc Approves Final DividendCroda International Plc at its AGM held on April 22, 2026 approved a final dividend of 63.0 pence per ordinary share.
공시 • Feb 25Croda International Plc, Annual General Meeting, Apr 22, 2026Croda International Plc, Annual General Meeting, Apr 22, 2026.
공시 • Feb 24Croda International plc Recommends Final Dividend for the Financial Year Ended December 31, 2025, Payable on 27 May 2026Croda International Plc announced that the Directors are recommending a final dividend of 63 pence per share amounting to a total of £87.9 million in respect of the financial year ended 31 December 2025. Subject to shareholder approval, the dividend will be paid on 27 May 2026 to shareholders registered on 10 April 2026. The total proposed dividend for the year ended 31 December 2025 will be 111 pence per share amounting to £154.9 million.
공시 • Jan 09Croda International Plc Announces Appointment of Jill Anderson as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees, Effective January 12, 2026Croda International Plc announced the appointment of Jill Anderson as a Non-Executive Director. Jill will join the Board on January 12, 2026 and become a member of the Audit, Nomination and Remuneration Committees. Jill brings more than 30 years' experience in international leadership positions in the healthcare industry, including executive responsibility in finance, commercial research and supply chain functions. Most recently, Jill was Chief Financial Officer of GSK's R&D division until she retired in 2024. Jill is currently a Non-Executive Director and Audit Committee Chair at Spire Healthcare Group plc.
공시 • Dec 24+ 1 more updateCroda International Plc to Report Fiscal Year 2026 Results on Feb 23, 2027Croda International Plc announced that they will report fiscal year 2026 results on Feb 23, 2027
공시 • Oct 17Croda International plc Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal Year 2025Croda International Plc provided earnings guidance for the fourth quarter and full year of fiscal year 2025. For the quarter, the company absolute sales in quarter 4 are likely to be seasonally lower than in the first 3 quarters as customers typically manage their working capital into the year-end. Despite this, the combination of good sales growth year-to-date and anticipated cost savings means that the company continue to expect GBP 265 million to GBP 295 million of group adjusted profit before tax at constant currency. For the full year, the company reiterated full year guidance.
공시 • Jul 31Croda International plc Announces an Interim Dividend in Respect of 2025, Payable on 7 October 2025Croda International Plc announced an interim dividend in respect of 2025 of 48.0 pence per share, amounting to a total dividend of £67.0 million, was declared by the Directors at their meeting on 25 July 2025. This interim report does not reflect the 2025 interim dividend payable. The dividend will be paid on 7 October 2025 to shareholders registered on 29 August 2025.
공시 • Mar 04Croda International Plc Announces Retirement of Julie Kim from the Board, Effective July 26, 2025Croda International Plc announced that Julie Kim will retire from the Board on 26 July 2025, having served four years as a non-executive director, in order to focus on her executive commitments. Julie has recently been named as the next CEO of Takeda Pharmaceutical.
공시 • Feb 26Croda International Plc, Annual General Meeting, Apr 23, 2025Croda International Plc, Annual General Meeting, Apr 23, 2025.
공시 • Feb 25Croda International plc Recommends Final Dividend for the Financial Year Ended December 31, 2024, Payable on May 28, 2025The Directors of Croda International Plc are recommending a final dividend of 63 pence per share amounting to a total of £87.9 million in respect of the financial year ended 31 December 2024. Subject to shareholder approval, the dividend will be paid on 28 May 2025 to shareholders registered on 11 April 2025. The total proposed dividend for the year ended 31 December 2024 will be 110 pence per share amounting to £153.5 million. The Board is proposing to increase the full year dividend to 110 pence (2023: 109 pence), despite temporarily taking company above its stated percentage of adjusted profit after tax, reflecting its confidence in delivery of future earnings growth.
공시 • Jan 22+ 1 more updateCroda International Plc to Report Fiscal Year 2025 Results on Feb 24, 2026Croda International Plc announced that they will report fiscal year 2025 results on Feb 24, 2026
공시 • Nov 19Croda International plc Announces Directorate ChangeCroda International Plc announced that John Ramsay, having served as a non-executive director and Chair of Audit Committee for over 5 years, will retire from the Board on 1 March 2025 and not seek re-election at the 2025 AGM (due to increased business and personal commitments). In preparation for John's retirement next year, Ian Bull will take over as Chair of the Audit Committee with effect from 1 December 2024 and so lead the Committee over Croda's 2024 year-end. Ian has been a member of the Audit Committee since his appointment to the Board on 24 June 2024. Ian is currently the Audit Committee Chair of Dunelm Group plc, Senior Independent Director at Domino's Pizza Group plc and Fellow of the Chartered Institute of Management Accountants. John will remain a member of the Audit Committee, as well as the Nomination and Remuneration Committees until his retirement from the Board.
공시 • Jul 01+ 1 more updateStephen Oxley to Join Croda International plc as Executive Director No Later Than 1 April 2025Croda International Plc announced that the Board has appointed Stephen Oxley as Executive Director. Stephen, a qualified accountant, is currently CFO of Johnson Matthey Plc, the specialty chemicals and sustainable technologies company. Stephen brings valuable experience in strategy setting and execution, enhancing business performance, transformation and corporate transactions. Stephen was previously a Partner at KPMG where he spent nearly 30 years advising global companies across consumer, healthcare and industrial sectors. He is also a Non-Executive Member of the Audit and Risk Committee for the Sovereign Grant which oversees the UK's public grant to the Royal Family. Stephen will join Croda no later than April 1, 2025 following a notice period. Anthony Fitzpatrick,President Strategy, Corporate Development & Industrial Specialties, has been appointed Interim Chief Financial Officer. Anthony joined Croda and the Executive Committee in 2014 having previously spent more than 20 years in global investment banking.
공시 • Jun 27Croda International Plc Appoints Ian Bull as Non-Executive Director and Member of the Audit, Nomination and Remuneration CommitteesThe Board of Croda International Plc announced the appointment of Ian Bull as a Non-Executive Director with effect from 25 June 2024. Ian has extensive experience with listed companies across a wide range of industries, both domestic and international, both as an Executive Director as well as Senior Independent Director and Audit Committee Chair. He was previously Group Finance Director of Greene King plc, Chief Financial Officer at Ladbrokes plc, and was most recently Chief Financial Officer of Parkdean Resorts Group. Ian was formerly a non-executive Director of Paypoint Ltd, Chair of Lookers plc and Senior Independent Director and Audit Committee Chair of St. Modwen Properties plc. Ian is currently a Non-Executive Director and Audit Committee Chair of Dunelm Group plc and Senior Independent Director of Domino's Pizza Group Plc. He is a Fellow of the Chartered Institute of Management Accountants. On joining the Board, Ian will be appointed to the Audit, Nomination and Remuneration Committees.
공시 • Apr 27Croda International Plc Declares Final DividendCroda International Plc at its Annual General Meeting held on 24 April 2024 declared a final dividend of 62.0 pence per ordinary share.
공시 • Feb 29Croda International plc Recommends Final Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on 29 May 2024The Directors of Croda International Plc are recommending a final dividend of 62.0 pence per share amounting to a total of £86.5m in respect of the financial year ended 31 December 2023. Subject to shareholder approval, the dividend will be paid on 29 May 2024 to shareholders registered on 19 April 2024. The total proposed dividend for the year ended 31 December 2023 will be 109.0pper share amounting to £152.1m.
공시 • Jan 30+ 1 more updateCroda International Plc to Report First Half, 2024 Results on Jul 30, 2024Croda International Plc announced that they will report first half, 2024 results on Jul 30, 2024
공시 • Dec 20Croda International plc Announces Louisa Burdett, Chief Financial Officer, Intends to Leave in June 2024Croda International Plc announced that Louisa Burdett, Chief Financial Officer, intends to leave the Company in June 2024 to become Chief Financial Officer at Spirax-Sarco Engineering plc.
공시 • Dec 19Croda International plc Announces Resignation of Louisa Burdett from BoardCroda International Plc announced that Louisa Burdett, Non-Executive Director, will leave the board in June 2024.
공시 • Sep 22+ 1 more updateCroda International Plc, Annual General Meeting, Apr 24, 2024Croda International Plc, Annual General Meeting, Apr 24, 2024.
공시 • Jul 06Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370).Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW 350 billion on February 3, 2023. The acquisition is subject to regulatory approval. Lazard & Co., Limited acted as financial advisor to Croda International Plc (LSE:CRDA).Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) on July 4, 2023. The acquisition comes following receipt of unconditional approval from the South Korean regulatory authorities.
공시 • Feb 07Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion.Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion on February 6, 2023. The acquisition is subject to regulatory approval.
공시 • Nov 07Croda International plc Announces Directorate ChangesCroda International Plc announced that Jez Maiden, Group Finance Director, has advised the Board that he will be retiring from the Company during 2023 after eight years in the role. The Board has appointed Louisa Burdett, until recently Chief Financial Officer ("CFO") of Meggitt Plc ("Meggitt"), the global aerospace, defence and energy component manufacturer, to succeed Jez. Jez joined Croda in January 2015, subsequently transforming the Finance, IT and Digital functions, and developing a broad, diverse pool of talent. He has modernised Croda's processes, introduced new standards of operational excellence and financial reporting, and closely supported the Chief Executive in the development and deployment of Croda's strategy. Jez led the creation of Croda's sustainability metrics, as well as its approach to capital allocation, which has underpinned shareholder value creation by enabling investment in organic growth, targeted acquisitions and strong returns. He also co-led the successful separation of the majority of Croda's Performance Technology and Industrial Chemicals businesses, accelerating the Company's transition to be a pure-play Consumer Care and Life Sciences business. Louisa has over ten years of experience successfully leading finance functions for UK listed companies. This includes four years as CFO of Meggitt, before it was acquired by Parker-Hannifin in September 2022, and five years as CFO of Victrex, the speciality chemicals company. Prior to that she held CFO positions with Optos plc, Financial Times Group, GE Healthcare, and CHEP Europe. Louisa is also Non-executive Director and Audit Committee Chair of RS Group Plc, the FTSE 100 distributor of industrial and electronic products. She has a first-class degree in biochemistry from Imperial College London and trained as an accountant before moving into her first in-house role at GSK. To enable a smooth transition, Louisa will join Croda and the Board on 1 January 2023. She will succeed Jez as Group Finance Director on 13 March 2023, following Croda's 2022 Full Year results at the end of February. Jez will step down from the Board at the Annual General Meeting on 26 April 2023 and retire from the Company on 31 May 2023.
공시 • Jul 23Croda International Plc Announces Board and Committee ChangesCroda International Plc announced that Dr Helena Ganczakowski will have served nine years as a director of Croda International Plc in 2023 and will therefore retire from the Board on 26 April 2023 following the AGM. In preparation for Helena's retirement next year, Jacqui Ferguson will take over as Chair of the Remuneration Committee with effect from 1 September 2022. This will give Jacqui a good period as Chair to prepare for the Committee's review of the Company's remuneration policy at the end of the year. Jacqui has been a member of the Remuneration Committee since 1 September 2018. Helena will remain a member of the Remuneration Committee and will continue in her role as the Senior Independent Director until her retirement from the Board.
공시 • Jul 02Cargill, Incorporated completed the acquisition of 77% stake in Performance Technologies and Industrial Chemicals Businesses from Croda International Plc (LSE:CRDA).Cargill, Incorporated signed a definitive agreement to acquire 77% stake in Performance Technologies and Industrial Chemicals Businesses from Croda International Plc (LSE:CRDA) for approximately £670 million on December 22, 2021. The divested business, which represented 77% of PTIC's 2020 revenue, is comprised of five manufacturing facilities, including the Gouda plant in the Netherlands, the Hull plant in the UK and Croda Sipo in China (a joint venture in which Croda owns 65%), together with additional laboratory facilities supporting key aspects of the divested business' activities in Smart Materials, Energy Technologies and Industrial Chemicals. The consideration of £780 million includes 100% of Sipo in the divested business. If the sale of 100% of Sipo cannot be realised, Sipo will be excluded from the sale, reducing the consideration by approximately £120 million. PTIC reported revenue of approximately £500 million and adjusted operating profit was £55.9 million for the period end on June 30, 2021. Croda intends to reinvest proceeds from the transaction into faster growth areas, increasing its exposure to health care and further developing its position as a sustainability leader in consumer care and crop care markets. The transaction is subject to receiving customary regulatory approvals but is not subject to approval by Croda's or Cargill's shareholders. Croda and Cargill are currently working together on the process to separate the two businesses, with completion of the transaction expected in Summer 2022. Shirav Patel and Andrew Foster of Morgan Stanley & Co. International Plc acted as financial advisors; James Hartop of Centerview Partners LLC acted as financial advisor; Oliver Lazenby, Giles Pratt, Holly Baker, Alastair Chapman, Alice Greenwell, Dawn Heath and Peter Clements of Freshfields Bruckhaus Deringer LLP acted as legal advisor; and Charlie Armitstead of Teneo Securities LLC acted as financial advisor to Croda in the transaction. HSBC is acting as a Sole Financial Adviser to Cargill Inc. Cargill, Incorporated completed the acquisition of 77% stake in Performance Technologies and Industrial Chemicals Businesses from Croda International Plc (LSE:CRDA) on July 1, 2022.
공시 • May 24Croda International plc Announces Final Dividend for the Financial Year Ended 31 December 2021Croda International Plc at the Annual General Meeting held on May 20, 2022 declared a final dividend of 56.5 pence per share of the financial year ended 31 December 2021.
공시 • Mar 04+ 2 more updatesCroda International Plc to Report Fiscal Year 2022 Results on Mar 07, 2023Croda International Plc announced that they will report fiscal year 2022 results on Mar 07, 2023
공시 • Mar 02Croda International plc Recommends Final Dividend for the Year Ended December 31, 2021, Payable on June 6, 2022Croda International Plc's directors are recommending a final dividend of 56.5 pence per share amounting to a total of £78.8 million in respect of the financial year ended 31 December 2021. Subject to shareholder approval, the dividend will be paid on 6 June 2022 to shareholders registered on 6 May 2022. The total proposed dividend for the year ended 31 December 2021 will be 100.0 pence per share amounting to £139.4 million.
공시 • Dec 24+ 1 more updateCargill Velocity Holdings Limited agreed to acquire an unknown majority stake in Bio-based industrial business from Croda International Plc (LSE:CRDA) for an enterprise value of approximately €920 million.Cargill Velocity Holdings Limited agreed to acquire an unknown majority stake in Bio-based industrial business from Croda International Plc (LSE:CRDA) for an enterprise value of approximately €920 million on December 22, 2021. The consideration is on a cash-free, debt-free basis. The divested business, which represented 77% of PTIC’s 2020 revenue, is comprised of five manufacturing facilities, including the Gouda plant in the Netherlands, the Hull plant in the UK and Croda Sipo in China (a joint venture in which Croda owns 65%), together with additional laboratory facilities supporting key aspects of the divested business’ activities in Smart Materials, Energy Technologies and Industrial Chemicals. The consideration of €915 million includes 100% of Sipo in the divested business. If the sale of 100% of Sipo cannot be realised, Sipo will be excluded from the sale, reducing the consideration by €140 million. The retained parts of PTIC will provide integral support to the Group’s Consumer Care and Life Sciences sectors. For last twelve month Bio-based industrial business reported revenue of €449.7 million and adjusted operating profit of €57.7 million. The transaction is subject to receiving customary regulatory approvals but is not subject to approval by Croda’s or Cargill’s shareholders. Croda and Cargill are currently working together on the process to separate the two businesses, with completion of the transaction expected in Summer 2022. Croda intends to reinvest proceeds from the transaction into faster growth areas, increasing its exposure to health care and further developing its position as a sustainability leader in consumer care and crop care markets.